TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Revision or reoperation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean % Change From Baseline in Trabecular Number (Tb.N)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Recurrent laryngeal nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: mRSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum Observed Plasma Concentration of NOMAC (Cmax of NOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline Corrected Maximum Observed Serum Concentration of E2 (Cmax of E2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time 0 to the Time of the Last Measurable Sample (AUC Last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy of Diabetes Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: eSAGE Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orphanin-FQ blood level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Depressive Symptoms at 5 Week
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Anxiety Symptoms at 5 Week
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Patients Achieving >= 50% Reduction in PSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of false positive alarm detections
Endpoint domain: Adverse events/effects
Primary endpoint: Binocular Defocus Curve at Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of the most bothersome VVA symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with the study protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction with the length of hospital stay after 1 week
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with the length of hospital stay after 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in knowledge of participants on under five pneumonia
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in confidence in skills for diagnosing and managing under five pneumonia
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increase in PD related metabolic pattern expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in PD related functional pattern expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and quality of intrusive thoughts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in neural response to an emotion recognition task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Short term CPAP Compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intermediate CPAP Compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Respiratory Quotient (RQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Genomic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional immunologic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in SNAP-IV ADHD Subscale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean blood pressor dose-response relationship
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Urinary Tract Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Numeric rating scale (NRS) - Headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Pregnancies Achieved Per Menstrual Cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Changes in DASS-21 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Hemoglobin A1C at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: degree of pain at 24-hours post-operative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time for first requested post-operative additional analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: opioid requirement with the first 24-hours post-operative
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: decreases in HbA1c values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neurological assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Viral load reduction from baseline through Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in lipids from baseline at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma concentration of coagulation factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Revised Scale for Caregiving Self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nodule Hardness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Phenotypic classification of AMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response (CR)/ CR with incomplete marrow recovery (CR/CRi) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: F1-score of FOG detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of FOG-episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the total duration of FOG-episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composition of intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and Negative Syndrome Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Specific Level of Functioning Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: HealthWatch-11 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prognostic factors of acute ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: N-Acetylaspartate Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Repigmentation area of vitiligo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pharmacokinetic parameters (Cmax, Tmax, t½, AUC0-T, AUC0-¥)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of donors from which induced Pluripotent Stem Cells were generated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Trunk Fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: circulating CD4+T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Overall Benefit of Analgesic Score (OBAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 24-hour Sensor output signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge of child development and behavior management strategies
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in General Self-Efficacy Scale (GSE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Measure of Job Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Biodistribution of [F-18]CP-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosimetry of [F-18]CP-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolite profile of [F-18]CP-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H-reflex of paretic soleus muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle stiffness of paretic medial gastrocnemius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: H-reflex of non-paretic soleus muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle stiffness of non-paretic medial gastrocnemius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Disease Activity Score for 28 Joints Based on C-reactive Protein (DAS28[CRP])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in skin spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scores on the California Verbal Learning Test (CVLT-II)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Scores on the Wisconsin Card Sorting Test (WCST)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Scores on the Conners' Continuous Performance Test (CPT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With New Brain Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of responders (PCR + CCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of ischemic stroke subtype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in HCV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants experiencing an adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants discontinuing from study therapy due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Subjects With SLE Responder Index Response at Week 24 (Screening Visit as Baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With SLE Responder Index Response at Week 24 (Day 1 as Baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advance Care Planning Engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Analogue Pain Scale (Burning Pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of days abstinent from illicit/non-medical opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of closed loop insulin delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma C-reactive protein (CRP) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with CDAI score < 150
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of acute exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline work done on a cycle ergometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TMAO concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of latent TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Body Satisfaction Scale (BSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Survivorship of Salto Talaris Ankle Implant
Endpoint domain: Mortality/survival
Primary endpoint: 100 day transplant related mortality
Endpoint domain: Mortality/survival
Primary endpoint: time to engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients achieving full engraftment by day +100
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse-Free Survival (RFS) rates
Endpoint domain: Mortality/survival
Primary endpoint: BB % Relative Dose (Mean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with Life (SWL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Blood levels of Sevoflurane and Desflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of Cin to Ccr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Unified Parkinson's disease rating scale Overall Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's Disease Questionnaire - 39 (PDQ39) Quality of Life Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hamilton anxiety and depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in patient reported pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: symptom free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days with no use of bronchodilator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days with no use of bronchodilator and no symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Suppressed Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in amplitude of tumor motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of GDC-9545
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Hour 0 to the Last Measurable Concentration (AUC0-t) of GDC-9545
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Elimination Half-Life (t1/2) of GDC-9545
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical ratings of schizophrenia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vocational skills
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: MVCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence rates of Diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Momentary Suicidal Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Predictive value of skin test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Up and Go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal drop in systemic hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Disease Activity Score (DAS28CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eyes in which radiation therapy can be omitted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eyes in which vision can be retained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-specific Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prostate Cancer Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Liver fibrosis assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion From Microalbuminuria to Normoalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Greater Than 50% Reduction in Microalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Severity of hyperhidrosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in physical activity level after pulmonary rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of Self-Efficacy using the PRAISE questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EFT volume measured by Cardiac MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: angiographic severity of coronary artery disease (Syntax Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived viscosity change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain-free period
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total narcotic use following surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Transfusion Units
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Health related quality of life (quality adjusted life years [QALYs])
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complications related to NEVELIA®
Endpoint domain: Adverse events/effects
Primary endpoint: Days until return to activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ankle-Brachial Pressure Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MVO/SVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) Pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Sarcoma occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Severity of unsafe swallows
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life in Epilepsy-10 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Daily Drinking Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Non-Hematological Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects That Initiated Cessation Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Healthy Subjects With AEs
Endpoint domain: Adverse events/effects
Primary endpoint: AUC(0-12h) of Deleobuvir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Deleobuvir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Environmentally-implicated Healthcare-Associated Infections (eiHAIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rectal Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of HCC based on methylation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Viral Load Below 400 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of Participants With Viral Load Below 50 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Photic blink reflex recovery cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cardiac Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overactive bladder symptoms scores (OABSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Consultation on Incontinence Questionnaire -- Short Form (ICIQ-SF)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of increased risk of serious infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Mean Total Contusion Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of CNS relapse
Endpoint domain: Mortality/survival
Primary endpoint: Number of steps per 24-hour day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in blood glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Patients Undergoing IDTFK
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: SHS exposure of non-smokers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tissue inflammation
Endpoint domain: Adverse events/effects